APA (7th ed.) Citation

Villares, M., Lourenço, N., Berthelet, J., Lamotte, S., Regad, L., Medjkane, S., . . . Weitzman, J. B. (2022). Trifloxystrobin blocks the growth of Theileria parasites and is a promising drug to treat Buparvaquone resistance. Communications Biology, 5(1), 1. https://doi.org/10.1038/s42003-022-03981-x

Chicago Style (17th ed.) Citation

Villares, Marie, et al. "Trifloxystrobin Blocks the Growth of Theileria Parasites and Is a Promising Drug to Treat Buparvaquone Resistance." Communications Biology 5, no. 1 (2022): 1. https://doi.org/10.1038/s42003-022-03981-x.

MLA (9th ed.) Citation

Villares, Marie, et al. "Trifloxystrobin Blocks the Growth of Theileria Parasites and Is a Promising Drug to Treat Buparvaquone Resistance." Communications Biology, vol. 5, no. 1, 2022, p. 1, https://doi.org/10.1038/s42003-022-03981-x.